CSF tau indicates neuronal death, and, therefore, it can be elevated in atypical phenotypes as well as in non-AD dementias; an increase in pTau is more specific to AD pathology in both typical and atypical presentations [25, 42]. The gene discussed is MAPT; the disease is Alzheimer disease.